| 1 |
pre-exposure prophylaxis
(2622 times)
|
Acquired Immunodeficiency Syndrome
(974 times)
|
MSM (547 times)
HIV (209 times)
ART (132 times)
|
2005 Tenofovir trials raise ethical issues.
|
| 2 |
Pre-exposure prophylaxis for HIV
(4 times)
|
Medicine
(1 time)
|
eGFR (1 time)
FP (1 time)
MSM (1 time)
|
2015 Determinants of HIV testing among Nigerian couples: a multilevel modelling approach.
|
| 3 |
pre-exposure
(3 times)
|
Allergy and Immunology
(1 time)
|
RVNA (2 times)
EU (1 time)
ID (1 time)
|
2011 Immunogenicity of Simulated PCECV Postexposure Booster Doses 1, 3, and 5 Years after 2-Dose and 3-Dose Primary Rabies Vaccination in Schoolchildren.
|
| 4 |
preexposure
(3 times)
|
Communicable Diseases
(2 times)
|
PEP (2 times)
aORs (1 time)
CI (1 time)
|
2013 Rabies immunization of travelers in a canine rabies endemic area.
|
| 5 |
pre-exposure prophylaxis for HIV prevention
(2 times)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
---
|
2019 Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP).
|
| 6 |
Prevention recommends pre-exposure prophylaxis
(2 times)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
PEP (1 time)
|
2020 PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
|
| 7 |
population, daily oral chemoprophylaxis
(1 time)
|
Communicable Diseases
(1 time)
|
---
|
2014 Strategies to manage the HIV epidemic in gay, bisexual, and other men who have sex with men.
|
| 8 |
Pre-exposure pharmacological prophylaxis
(1 time)
|
Legislation, Drug
(1 time)
|
---
|
2017 Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties.
|
| 9 |
preexposure prophylaxis for HIV-1 infection
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
BMGF (1 time)
CDC (1 time)
DAIDS (1 time)
|
2011 Implications of HIV PrEP trials results.
|
| 10 |
preexposure prophylaxis with antiretrovirals
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
---
|
2011 AIDS vaccines and preexposure prophylaxis: is synergy possible?
|
| 11 |
Prenatal epigenetic programming
(1 time)
|
Autistic Disorder
(1 time)
|
EAAT3 (1 time)
GI (1 time)
PEP (1 time)
|
2012 Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism.
|
| 12 |
program is the first key population-led
(1 time)
|
Public Health
(1 time)
|
aOR (1 time)
MSM (1 time)
TGW (1 time)
|
2019 Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women.
|
| 13 |
protective effect of preexposure prophylaxis
(1 time)
|
Medicine
(1 time)
|
dATP (1 time)
dCTP (1 time)
dNTP (1 time)
|
2016 Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.
|
A Search Service for Abbreviation / Long Form